OTC - ACTIVE INGREDIENT SECTION
Dideoyl Dimethyl Ammonium Chloride 0.025%
Dideoyl Dimethyl Ammonium Chloride 0.025%
Disinfectant
Uses: temporarily relieves these symptoms dueto hay fever or other upper respiratory allergies
For extemal use only, Stop using and ask a doctorif rash or initation happens.
Do not use: In children less than 2years old. On open skin wounds.
When Using: when using, keepout of eyes, ears ,mouth and anyopen hurt skin area.In case ofcontact with eyes, rinse eyesthoroughly with water.
Stop Use: Stop using and ask adoctor if irritation or rash occurs
Keep out of reach of children. lf swallowed, get medical help orcontact the Poison Control Centerright away.
1. Apply daily after cleansing and toning. Twice aday for at least 4 weeks.
2.Dispense a pea-size amount of the essence ontothe problematic area and use fingertips to massageuntil fully absorbed.
3.keep using it for a period of time until the miliadoesn't appear again.
Glycerin
Salicylic acid
Xanthan gum
Ampelopsin
Tocopheryl Acetate
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84735-006-01 | MILIA REMOVER TREATMENT | 1 in 1 BOX | LIQUID | 1 | 4 | |
| 84735-006-01 | MILIA REMOVER TREATMENT | 30 mL in 1 BOTTLE | LIQUID | 30 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84735-006 | 84735-006-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GLYCERIN | PDC6A3C0OX | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| SALICYLIC ACID | O414PZ4LPZ | IACT |
| DIDECYLDIMONIUM | Z7F472XQPA | ACTIB |
| DIHYDROMYRICETIN | KD8QND6427 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 35a13839-b5ed-19ab-e063-6294a90a7115 | 31b27fa8-6f54-a265-e063-6394a90a19c3 | 2025-05-21 | Warnings | 35a13839-b5ed-19ab-e063-6294a90a7115 31b27fa8-6f54-a265-e063-6394a90a19c3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.